iPSC Cells, Human, Disease
Applied StemCell offers human iPS cell lines derived from PBMCs, dermal fibroblasts, or adipose tissue of patients with Parkinson’s Disease (PD) and Diabetes II. These iPS cells are established from a single clone and expanded in feeder-free conditions. These patient-derived iPSCs lines provide a physiologically relevant toolset for in vitro disease modeling for applications in basic and applied research.
We also offer other iPSC lines and custom services in our stem cell pipeline:
ASE-9028: Sporadic Parkinson’s disease line
- Hsieh, C. H., Shaltouki, A., Gonzalez, A. E., da Cruz, A. B., Burbulla, L. F., Lawrence, E. S., ... & Wang, X. (2016). Functional impairment in Miro degradation and mitophagy is a shared feature in familial and sporadic Parkinson’s disease. Cell Stem Cell, 19(6), 709-724.